News

Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...
Insmed Incorporated: Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update
Total Revenue of $92.8 Million for the First Quarter of 2025, Reflecting 23% Growth Over the First Quarter of 2024- -NDA ...
Gauging Qorvo's Financial Stance
Qorvo achieves $869M revenue, driven by iPhone RF growth & diverse markets like automotive & defense. Find out more about its ...